Solid Tumors Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

Solid Tumors Stocks Recent News

Date Stock Title
May 8 EBS Looking Into Emergent BioSolutions's Recent Short Interest
May 8 CRIS Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript
May 7 LYEL Lyell Immunopharma to Participate in BofA Securities Health Care Conference
May 7 STTK What Makes Shattuck Labs (STTK) a New Buy Stock
May 7 STTK Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
May 7 ALXO ALX Oncology Appoints Allison Dillon as Chief Business Officer
May 7 CRIS Curis GAAP EPS of -$2.05, revenue of $2.1M
May 7 CRIS Curis Provides First Quarter 2024 Business Update
May 7 FUSN Fusion Pharmaceuticals GAAP EPS of -$0.40
May 7 FUSN Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates
May 7 LYEL Lyell Immunopharma First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)
May 6 MRUS FDA accepts Merus application for Zeno for lung, pancreatic cancer
May 6 MRUS Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC
May 6 CRIS Curis Q1 2024 Earnings Preview
May 6 LYEL Lyell Immunopharma reports Q1 results
May 6 LYEL Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
May 4 STTK Shattuck Labs First Quarter 2024 Earnings: Beats Expectations
May 4 STTK Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Results
May 2 CLLS Cellectis announces CFO departure
May 2 CLLS Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
Solid Tumors

Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

Browse All Tags